Adamas Pharmaceuticals (ADMS) Short Interest Ratio & Short Volume → Urgent alert: open this for a huge profit potential (From Timothy Sykes) (Ad) Free ADMS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Adamas Pharmaceuticals Short Interest DataCurrent Short Volume477,300 sharesPrevious Short Volume881,300 sharesChange Vs. Previous Month-45.84%Dollar Volume Sold Short$3.88 millionShort Interest Ratio / Days to Cover0.4Last Record DateNovember 15, 2021Outstanding Shares45,787,000 sharesFloat Size39,880,000 sharesShort Percent of Float1.20%Today's Trading Volume0 sharesAverage Trading Volume692,487 sharesToday's Volume Vs. Average0% Short Selling Adamas Pharmaceuticals ? Sign up to receive the latest short interest report for Adamas Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADMS Short Interest Over TimeADMS Days to Cover Over TimeADMS Percentage of Float Shorted Over Time Ad Market Moving TrendsTop 5 AI Stocks to Buy for 20245 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In" Adamas Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/2021477,300 shares $3.88 million -45.8%1.2%0.4 $8.13 10/29/2021881,300 shares $7.15 million -44.9%2.2%0.8 $8.11 10/15/20211,600,000 shares $12.91 million -32.2%4.0%1.5 $8.07 9/30/20212,360,000 shares $11.59 million -6.0%5.9%3.4 $4.91 9/15/20212,510,000 shares $11.67 million +2.5%6.3%11 $4.65 8/31/20212,450,000 shares $11.54 million -2.8%6.2%9.8 $4.71 Get the Latest News and Ratings for ADMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adamas Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/13/20212,520,000 shares $11.34 million +2.0%6.4%8.6 $4.50 7/30/20212,470,000 shares $11.81 million +7.9%6.3%9 $4.78 7/15/20212,290,000 shares $11.75 million +7.0%5.8%7.5 $5.13 6/30/20212,140,000 shares $11.30 million +0.9%5.5%6.2 $5.28 6/15/20212,120,000 shares $10.62 million -4.1%5.4%6.3 $5.01 5/28/20212,210,000 shares $12.22 million -3.5%5.6%6.1 $5.53 5/14/20212,290,000 shares $11.22 million -5.4%N/A4.8 $4.90 4/30/20212,420,000 shares $13.60 million +1.3%N/A4.6 $5.62 4/15/20212,390,000 shares $11.81 million +1.7%N/A3.1 $4.94 3/31/20212,350,000 shares $11.28 million +4.4%N/A3.2 $4.80 3/15/20212,250,000 shares $11.27 million +13.1%N/A3.2 $5.01 2/26/20211,990,000 shares $9.45 million +115.5%N/A3 $4.75 2/12/2021923,500 shares $5.70 million -47.8%4.0%1.7 $6.17 1/29/20211,770,000 shares $9.50 million +47.5%7.7%3.7 $5.37 1/15/20211,200,000 shares $5.44 million -4.0%5.2%5.5 $4.53 12/31/20201,250,000 shares $5.66 million -23.3%5.5%7 $4.53 12/15/20201,630,000 shares $7.86 million +40.5%7.1%8.6 $4.82 11/30/20201,160,000 shares $5.16 million -1.7%5.1%5.7 $4.45 11/15/20201,180,000 shares $4.70 million -1.7%5.2%5.3 $3.98 10/30/20201,200,000 shares $3.94 million +60.3%5.2%4.3 $3.28 10/15/2020748,500 shares $3.59 million +1.5%3.3%1.5 $4.79 9/30/2020737,300 shares $3.04 million -6.3%3.3%1.5 $4.12 9/15/2020787,200 shares $3.39 million -8.0%3.5%1.4 $4.31 8/31/2020855,400 shares $4.43 million -17.8%3.8%1.4 $5.18 8/14/20201,040,000 shares $4.99 million +32.9%4.6%1.6 $4.80 7/31/2020782,600 shares $1.94 million +9.4%3.5%1.2 $2.48 7/15/2020715,600 shares $1.92 million -23.2%3.2%1.7 $2.68 6/30/2020931,400 shares $2.34 million -26.7%4.1%2 $2.51 6/15/20201,270,000 shares $3.52 million +22.1%5.6%3.1 $2.77 5/29/20201,040,000 shares $2.90 million -11.1%4.6%2.7 $2.79 5/15/20201,170,000 shares $3.11 million +14.7%5.2%3.1 $2.66 4/30/20201,020,000 shares $3.29 million -4.7%4.5%2.9 $3.23 4/15/20201,070,000 shares $3.57 million -10.8%4.8%3.1 $3.34 3/31/20201,200,000 shares $3.97 million -9.5%5.4%2.8 $3.31AI “wealth window” is closing soon! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… ADMS Short Interest - Frequently Asked Questions What is Adamas Pharmaceuticals' current short interest? Short interest is the volume of Adamas Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 477,300 shares of ADMS short. 1.20% of Adamas Pharmaceuticals' shares are currently sold short. Learn More on Adamas Pharmaceuticals' current short interest. What is a good short interest percentage for Adamas Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.20% of Adamas Pharmaceuticals' floating shares are currently sold short. Is Adamas Pharmaceuticals' short interest increasing or decreasing? Adamas Pharmaceuticals saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 477,300 shares, a decline of 45.8% from the previous total of 881,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adamas Pharmaceuticals' float size? Adamas Pharmaceuticals currently has issued a total of 45,787,000 shares. Some of Adamas Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adamas Pharmaceuticals currently has a public float of 39,880,000 shares. How does Adamas Pharmaceuticals' short interest compare to its competitors? 1.20% of Adamas Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Adamas Pharmaceuticals: Organogenesis Holdings Inc. (9.35%), Amarin Co. plc (4.39%), Nkarta, Inc. (9.81%), ADC Therapeutics SA (1.81%), Adlai Nortye Ltd. (0.02%), Esperion Therapeutics, Inc. (11.82%), Atai Life Sciences (4.81%), Nature's Sunshine Products, Inc. (0.60%), Revance Therapeutics, Inc. (13.00%), PepGen Inc. (1.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Kansas City Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks. What does it mean to sell short Adamas Pharmaceuticals stock? Short selling ADMS is an investing strategy that aims to generate trading profit from Adamas Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adamas Pharmaceuticals? A short squeeze for Adamas Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADMS, which in turn drives the price of the stock up even further. How often is Adamas Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADMS, twice per month. The most recent reporting period available is November, 15 2021. More Short Interest Resources from MarketBeat Related Companies: ORGO Short Interest Data AMRN Short Interest Data NKTX Short Interest Data ADCT Short Interest Data ANL Short Interest Data ESPR Short Interest Data ATAI Short Interest Data NATR Short Interest Data RVNC Short Interest Data PEPG Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADMS) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBiden out June 13; Kamala won’t replace him?Paradigm PressOptions trading has suddenly become more reliable.Eagle PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings